The Most Common Diagnosis You Have Never Heard Of
Functional gastrointestinal disorders — now formally termed Disorders of Gut-Brain Interaction (DGBI) — affect an estimated 40 percent of the global population. They include irritable bowel syndrome, functional dyspepsia, functional constipation, and over 30 other conditions defined by the Rome criteria. Despite their extraordinary prevalence, they are often dismissed by both doctors and patients as "not real" because standard investigations — blood tests, endoscopy, imaging — return normal results.
This dismissal is wrong. Functional does not mean imaginary. It means that the dysfunction lies not in structural damage visible under a microscope, but in disordered communication between the gut and the brain — altered motility, heightened visceral sensation, dysregulated immune activation, and disrupted microbiome signalling.
The Biopsychosocial Model
The modern understanding of DGBI rests on the biopsychosocial model proposed by George Engel and adapted for gastroenterology by Douglas Drossman. This framework recognises that biological factors (visceral hypersensitivity, altered motility, low-grade mucosal inflammation, microbiome changes), psychological factors (anxiety, depression, trauma history, catastrophising), and social factors (learned illness behaviour, healthcare experiences, cultural attitudes) all interact to produce and perpetuate symptoms.
No single factor is sufficient. A patient might have visceral hypersensitivity (biological) amplified by health anxiety (psychological) in a context where previous doctors dismissed their symptoms (social) — creating a self-reinforcing cycle of symptom vigilance, stress, and gut dysfunction.
Visceral Hypersensitivity
A key mechanism in many DGBI is visceral hypersensitivity — an amplified perception of normal gut signals. Balloon distension studies show that IBS patients report pain at significantly lower volumes and pressures than healthy controls. This is not malingering or exaggeration; functional brain imaging reveals genuinely increased activation of pain-processing regions (anterior cingulate cortex, insula) in response to the same physical stimulus.
The hypersensitivity can be peripheral (sensitised nerve endings in the gut wall, often following infection or inflammation) or central (altered pain processing in the brain and spinal cord). Post-infectious IBS — developing after a bout of gastroenteritis — is a clear example of peripheral sensitisation, with residual low-grade inflammation and increased mucosal mast cells even after the infection has cleared.
Why It Matters
DGBI are the most common reason for gastroenterology referral. They account for enormous healthcare costs, workplace absenteeism, and reduced quality of life. Effective treatment exists — dietary modification (low-FODMAP), gut-directed hypnotherapy, cognitive behavioural therapy, neuromodulators (low-dose antidepressants used for their visceral analgesic properties), and targeted pharmacotherapy — but requires accurate diagnosis, patient education, and a therapeutic relationship built on taking symptoms seriously.
The first step in helping a patient with a functional disorder is believing them.